P
Phenomicshealth
An Artificial Intelligence-Powered Patient-Focused Precision Medicine company
About Phenomicshealth
Phenomics Health Inc. operates as a bioinformatics-based precision medicine company, established in 2018 by co-founders James S. Burns and Brian D. Athey. Headquartered in Plymouth, Michigan, the firm focuses on translating complex medical big data, including genetics and epigenetics, into actionable clinical treatment decision support tools for healthcare providers. The company's core offering is its proprietary AI-driven platform, which analyzes patient-specific data to help clinicians optimize medication selection and dosage. This technology addresses critical issues in healthcare such as adverse drug reactions (ADRs), patient adherence, and polypharmacy—the simultaneous use of multiple drugs.
Read full description
The company's primary product, the PredictMed Platform, utilizes artificial intelligence and machine learning to analyze drug-gene interactions, patient drug response, and potential side effects. It aims to provide a comprehensive view of a patient's medication profile by not only predicting responses based on genetics but also by directly measuring medication levels in a patient's system. This dual approach allows healthcare providers to more accurately assess medication adherence and interactions. In November 2019, Phenomics Health acquired the patented pharmacometabolomic technology portfolio from Precera Bioscience, enhancing its platform's capabilities to measure over 200 medications in a patient's bloodstream. This service is intended to be licensed to clinical laboratories and healthcare systems.
Phenomics Health serves healthcare providers and health systems, aiming to improve patient outcomes and reduce costs associated with ineffective medication therapy and adverse reactions. The company has secured $11.5 million in a Series A funding round on October 28, 2022, to support its expansion and further product development. The discoveries that form the basis of the company's technology originated from the University of Michigan Medical School, with which it has exclusive license agreements. The firm also utilizes its platform to support clinical trials through patient-trial matching and safety analytics.
At a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Plymouth Township, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 38.8/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Precision Medicine, Spinout, Biotech and Pharma, AI Drug Discovery, Techbio
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2022 | $20M | $78M | Undisclosed | ↗ |
| SPINOUT✓Other financing | Jan 2018 | $0 | — | University of Michigan | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Phenomicshealth is 2.6K monthly website visits, up 136.4% over the last three months. Phenomicshealth's team declined 6.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
University of Michigan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phenomicshealth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phenomicshealth’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.